MNG
BMRN icon

Manning & Napier Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$101M Buy
1,153,785
+8,672
+0.8% +$757K 1.15% 29
2023
Q4
$110M Buy
1,145,113
+6,161
+0.5% +$594K 1.31% 21
2023
Q3
$101M Buy
1,138,952
+1,193
+0.1% +$106K 1.25% 22
2023
Q2
$98.6M Buy
1,137,759
+37,041
+3% +$3.21M 1.13% 28
2023
Q1
$107M Buy
1,100,718
+226,152
+26% +$22M 1.25% 21
2022
Q4
$90.5M Sell
874,566
-57,225
-6% -$5.92M 1.11% 23
2022
Q3
$79M Sell
931,791
-14,610
-2% -$1.24M 1.03% 24
2022
Q2
$78.4M Sell
946,401
-758,954
-45% -$62.9M 0.91% 35
2022
Q1
$131M Sell
1,705,355
-31,704
-2% -$2.44M 1.25% 24
2021
Q4
$153M Sell
1,737,059
-5,922
-0.3% -$523K 1.28% 22
2021
Q3
$135M Buy
1,742,981
+15,597
+0.9% +$1.21M 1.16% 27
2021
Q2
$144M Buy
1,727,384
+22,542
+1% +$1.88M 1.18% 22
2021
Q1
$129M Buy
1,704,842
+621,482
+57% +$46.9M 1.09% 23
2020
Q4
$95M Sell
1,083,360
-49,358
-4% -$4.33M 0.88% 35
2020
Q3
$86.2M Buy
1,132,718
+162,195
+17% +$12.3M 0.87% 34
2020
Q2
$120M Sell
970,523
-79,835
-8% -$9.85M 1.28% 24
2020
Q1
$88.8M Sell
1,050,358
-49,833
-5% -$4.21M 1.05% 32
2019
Q4
$93M Buy
1,100,191
+370,098
+51% +$31.3M 1% 29
2019
Q3
$49.2M Buy
730,093
+4,032
+0.6% +$272K 0.55% 48
2019
Q2
$62.2M Sell
726,061
-184,898
-20% -$15.8M 0.68% 42
2019
Q1
$80.9M Sell
910,959
-88,959
-9% -$7.9M 0.89% 32
2018
Q4
$85.1M Sell
999,918
-404,610
-29% -$34.5M 1.04% 32
2018
Q3
$136M Sell
1,404,528
-479,145
-25% -$46.5M 1.34% 19
2018
Q2
$177M Sell
1,883,673
-32,785
-2% -$3.09M 1.75% 17
2018
Q1
$155M Sell
1,916,458
-64,419
-3% -$5.22M 1.52% 21
2017
Q4
$177M Buy
+1,980,877
New +$177M 1.59% 16